pyrrolidonecarboxylic acid has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezikov, E; Bischoff, R; de Boer, RA; Domian, IJ; Gil, A; Hoes, M; Ovchinnikova, ES; Silljé, HHW; Tromp, J; van de Sluis, B; van der Harst, P; van der Meer, P; van der Pol, A; van Deursen, JM; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Vreeswijk-Baudoin, I | 1 |
| Gur, ES; Kahveci, N; Korfali, E; Ozgüç, H; Serdar, Z; Tokyay, R | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Reperfusion Injury
| Article | Year |
|---|---|
Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.
Topics: Animals; Cardiotonic Agents; ERRalpha Estrogen-Related Receptor; Fetus; Heart Failure; Heart Function Tests; Humans; Mice, Transgenic; Myocardial Infarction; Myocardium; Oxidative Stress; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Receptors, Estrogen; Reperfusion Injury; Sequence Analysis, RNA; Stress, Mechanical; Transcription, Genetic | 2017 |
Oxothiazolidine carboxylate provides protection against hepatocellular injury seen after porta hepatis occlusion (Pringle maneuver) under hypovolemic conditions.
Topics: Animals; Constriction; Hepatic Artery; Hypovolemia; Liver; Male; Models, Animal; Portal Vein; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thiazoles; Thiazolidines | 2003 |